BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7753446)

  • 1. Beta 2-microglobulin-related amyloidosis: where do we stand?
    Gejyo F; Arakawa M
    Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
    [No Abstract]   [Full Text] [Related]  

  • 2. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
    Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
    J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
    Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
    Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HLA-B27 antigens in patients with dialysis-related beta 2-M amyloidosis.
    Charmes JP; Drouet M; Leroux-Robert C; Ton That H; Bouteiller G
    Clin Nephrol; 1991 Oct; 36(4):214. PubMed ID: 1959251
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amyloid arthropathy in hemodialysis patients].
    Muñoz Gómez J
    Med Clin (Barc); 1987 Feb; 88(5):192-4. PubMed ID: 3550308
    [No Abstract]   [Full Text] [Related]  

  • 8. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.
    Miyata T; Maeda K
    Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015
    [No Abstract]   [Full Text] [Related]  

  • 9. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
    Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
    J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amyloidosis associated with dialysis].
    Fernández E; Torras J
    Med Clin (Barc); 1990 Mar; 94(12):451-3. PubMed ID: 2195253
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis-related amyloidosis.
    Bardin T; Zingraff J; Kuntz D; Drüeke T
    Nephrol Dial Transplant; 1986; 1(3):151-4. PubMed ID: 3110668
    [No Abstract]   [Full Text] [Related]  

  • 12. B2-microglobulin and associated amyloidosis presenting as bilateral popliteal tumors.
    Reese W; Hopkovitz A; Lifschitz MD
    Am J Kidney Dis; 1988 Oct; 12(4):323-5. PubMed ID: 3052048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amyloid fibril formation of beta 2-microglobulin].
    Goto Y; Hoshino M
    Tanpakushitsu Kakusan Koso; 2002 May; 47(6):663-9. PubMed ID: 11995332
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis of amyloidosis: a role for anti-proteases?].
    Argilés i Ciscart A; Mourad G
    Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carpal tunnel syndrome in hemodialysis patients].
    Takayama K; Kawai H; Nabeshima K; Akizawa T
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):150-3. PubMed ID: 11031919
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of beta 2-microglobulin amyloid 10 years after renal transplantation.
    Kessler M; Aymard B; Pourel J
    Nephrol Dial Transplant; 1994; 9(3):333-4. PubMed ID: 8052450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 18. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM; Jaber BL
    Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.
    Brancaccio D; Anelli A; Gallieni M; Padovese P; Coggi G; Uslenghi C
    Contrib Nephrol; 1990; 77():177-86. PubMed ID: 2188786
    [No Abstract]   [Full Text] [Related]  

  • 20. Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.
    Hardouin P; Flipo RM; Foissac-Gegoux P; Dumont A; Duquesnoy B; Delcambre B
    Clin Rheumatol; 1988 Mar; 7(1):41-5. PubMed ID: 3044672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.